Goonaseelan (Colin) Pillai is committed to driving programs that develop scientific capability in low and middle-income countries.
A clinical pharmacologist who trained in Durban, South Africa, Colin previously led the Modeling & Simulation-Pharmacology group at Novartis. He has a specialist interest in the application of non-linear mixed effects models to pharmacokinetic-pharmacodynamic data across a wide range of therapeutic areas.
Colin has held teaching, research and management positions at the Universities of Durban-Westville and Witwatersrand. He acquired his clinical and research experience in hospital and community pharmacy and as a consultant with the SA Medical Research Council’s Tuberculosis Research program, where he ran a unit conducting Phase 1 clinical trials. Colin continues to maintain active academic links with numerous institutions in Africa including via formal Honorary Professorships and Board Member status. Since November 2017, he is a Senior Advisor on capacity development and training programs for global health to the Bill and Melinda Gates Foundation